NasdaqGS - Nasdaq Real Time Price • USD Henry Schein, Inc. (HSIC) Follow Compare 69.67 -1.39 (-1.96%) At close: January 10 at 4:00:02 PM EST 69.21 -0.46 (-0.66%) After hours: January 10 at 5:06:02 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Henry Schein Opens Customer Emergency Support Hotline in Response to California Fires MELVILLE, N.Y., January 09, 2025--Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers throughout California that the Henry Schein Customer Emergency Support Hotline is open for dental and medical professionals who may experience operational, logistical, or financial issues as a result of damage caused by the ongoing fires. Headline Risks Affecting Healthcare Tech & Distribution Sector Will Likely Continue in 2025: BofA Analyst BofA Securities predicts that headline risks affecting the Healthcare Tech & Distribution sector in 2024 will likely continue in 2025. Key areas of concern include pharmacy benefit managers (PBMs), retail pharmacies, distributors, fertility benefits, and direct-to-consumer (D2C) pharmacies. While regulatory pressure on PBMs is expected to persist, the analyst believes this will mainly impact profit margins and growth rates rather than lead to major changes in the business model. Potential policy Henry Schein Stock to Gain From New Acquisitions Amid Macro Woes Henry Schein has strategically set up distribution centers worldwide to better serve customers and increase its operating efficiency. Why This 1 Value Stock Could Be a Great Addition to Your Portfolio Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. The Celebrity Activist Investor Is Going Extinct An era of big-name activists with fiery personalities waging noisy proxy battles and wielding brash tactics to win board seats is over. Carl Icahn, facing attacks on how he manages his own publicly traded firm, has slowed his fire. Nelson Peltz, fresh off losing a battle with Disney is planning to hand his firm to his less pugnacious son and others. Should You Retain Henry Schein Stock in Your Portfolio Right Now? Investors are optimistic about HSIC owing to the performance of its dental business. Is Henry Schein, Inc. (NASDAQ:HSIC) Potentially Undervalued? Henry Schein, Inc. ( NASDAQ:HSIC ), might not be a large cap stock, but it saw significant share price movement during... Henry Schein to Participate at J.P. Morgan’s Healthcare Investor Conference MELVILLE, N.Y., December 17, 2024--Henry Schein to participate at J.P. Morgan's Healthcare Investor Conference. Here's Why Henry Schein (HSIC) is a Strong Value Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players? On Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc. (NASDAQ:PDCO), a dental and animal health product distributor, for approximately $4.1 billion. During its second-quarter earnings release, the company announced it is exploring strategic options, including a sale or merger, to boost shareholder value. William Blair notes that based on Patient Square Capital’s portfolio, which doesn’t include dental or animal health companies, regulator Henry Schein (HSIC) Up 6.4% Since Last Earnings Report: Can It Continue? Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. HSIC Stock Likely to Gain From Its Latest Acquisition of Acentus Henry Schein inked a new agreement to acquire Acentus to enhance its ability to deliver CGM products directly to patients' homes. Henry Schein to Participate in Investor Conferences in December MELVILLE, N.Y., November 21, 2024--Henry Schein to participate in investor conferences in December. Henry Schein to acquire medical supplier Acentus Acentus, which specializes in supplying glucose sensors to patients’ homes, continues Henry Schein’s recent focus on building its homecare medical supplies business. Henry Schein to Acquire Acentus, a Leading Supplier of Homecare Medical Products MELVILLE, N.Y., November 20, 2024--Henry Schein to acquire Acentus, a leading supplier of homecare medical products. Update: Market Chatter: Henry Schein's Activist Investor Seeks Board Overhaul, Divestment, Cost Cuts Update: Market Chatter: Henry Schein's Activist Investor Seeks Board Overhaul, Divestment, Cost Cuts S&P 500 Gains and Losses Today: Uber Falls as Trump Eyes Looser Self-Driving Rules The S&P 500 added 0.4% on Monday, Nov. 18, kicking off a trading week that will feature a highly anticipated earnings report from chip giant Nvidia. Exclusive-Activist investor Ananym Capital pushes for changes at Henry Schein, sources say NEW YORK (Reuters) -Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut costs, tackle succession planning and consider selling its medical distribution business, sources close to matter said on Monday. A sale of the medical distribution business could help drive up the share price by roughly 20%, while earnings per share could jump by some 35% if spending were curtailed, Ananym has told Schein executives, according to the sources. Henry Schein shares closed up 7.5% at $73.89 on Monday. UBS: Henry Schein, Inc. (NASDAQ:HSIC) Is A Bottom-Ranked Quant Stock We recently made a list of UBS’ Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors. In this piece, we will look at where Henry Schein, Inc. (NASDAQ:HSIC) ranks on the list of UBS’ bottom quant stocks. With November 2024 having settled in and the US presidential election in its […] Performance Overview Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return HSIC S&P 500 YTD +0.72% -1.35% 1-Year -7.18% +22.51% 3-Year -11.75% +24.59%